BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1938689)

  • 1. Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli.
    Fantin B; Ebert S; Leggett J; Vogelman B; Craig WA
    J Antimicrob Chemother; 1991 Jun; 27(6):829-36. PubMed ID: 1938689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of beta-lactam antibiotics on gram-negative bacteria: initial killing, morphology and postantibiotic effect.
    Hanberger H; Nilsson LE; Maller R; Nilsson M
    Scand J Infect Dis Suppl; 1990; 74():118-23. PubMed ID: 2129063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method.
    Isaksson B; Nilsson L; Maller R; Sörén L
    J Antimicrob Chemother; 1988 Jul; 22(1):23-33. PubMed ID: 3139614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
    Hostacká A
    J Basic Microbiol; 1998; 38(5-6):383-8. PubMed ID: 9871334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria.
    Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
    Scand J Infect Dis Suppl; 1990; 74():129-32. PubMed ID: 2129064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
    Bartmann K; Tarbuc R
    Infection; 1982; 10(6):361-70. PubMed ID: 6818153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli.
    Parsley TL; Provonchee RB; Glicksman C; Zinner SH
    Antimicrob Agents Chemother; 1977 Sep; 12(3):349-52. PubMed ID: 410362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo postantibiotic effect in a thigh infection in neutropenic mice.
    Vogelman B; Gudmundsson S; Turnidge J; Leggett J; Craig WA
    J Infect Dis; 1988 Feb; 157(2):287-98. PubMed ID: 3121761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections.
    Craig WA; Redington J; Ebert SC
    J Antimicrob Chemother; 1991 May; 27 Suppl C():29-40. PubMed ID: 1830302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of five aminoglycosides for treatment.
    Rosin H; Naumann P; Reintjens E; Köhler M
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods].
    Okubo T; Iyobe S
    Jpn J Antibiot; 2002 Oct; 55(5):514-23. PubMed ID: 12532635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.
    John JF; Twitty JA
    Antimicrob Agents Chemother; 1984 Nov; 26(5):781-4. PubMed ID: 6440481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postantibiotic effects of gentamicin and netilmicin on Serratia marcescens: effects on hydrophobicity and motility.
    Majtánová L; Majtán V
    Folia Microbiol (Praha); 2000; 45(1):45-9. PubMed ID: 11200671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The postantibiotic effect induced by antimicrobial combinations.
    Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
    Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.